Enhancing the efficacy of B7-H3-targeting antibody-drug conjugate DS-7300a in TP53-deficient tumors by inducing ferroptosis.
- DOI
- 10.1038/s41388-026-03921-7
- Published
- 2026 Sep
- Container
- Oncogene
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41388-026-03921-7,
title = {Enhancing the efficacy of B7-H3-targeting antibody-drug conjugate DS-7300a in TP53-deficient tumors by inducing ferroptosis.},
author = {Leo J and Chen F and Shi W and Liang X and Meng C and Gu Q and Albittar Y and Fan Z and Zhang J and Gan B and Goswami S and Carmon KS and Frigo DE and Aparicio A and Zhao D},
year = {2026},
journal = {Oncogene},
doi = {10.1038/s41388-026-03921-7},
url = {https://doi.org/10.1038/s41388-026-03921-7}
}RIS
TY - JOUR TI - Enhancing the efficacy of B7-H3-targeting antibody-drug conjugate DS-7300a in TP53-deficient tumors by inducing ferroptosis. AU - Leo J AU - Chen F AU - Shi W AU - Liang X AU - Meng C AU - Gu Q AU - Albittar Y AU - Fan Z AU - Zhang J AU - Gan B AU - Goswami S AU - Carmon KS AU - Frigo DE AU - Aparicio A AU - Zhao D PY - 2026 JO - Oncogene DO - 10.1038/s41388-026-03921-7 UR - https://doi.org/10.1038/s41388-026-03921-7 ER -
APA
J, L., F, C., W, S., X, L., C, M., Q, G., Y, A., Z, F., J, Z., B, G., S, G., KS, C., DE, F., A, A., & D, Z. (2026). Enhancing the efficacy of B7-H3-targeting antibody-drug conjugate DS-7300a in TP53-deficient tumors by inducing ferroptosis.. Oncogene. https://doi.org/10.1038/s41388-026-03921-7
Source records
- pubmed · retrieved 2026-09-26T01:27:04.632Z
- europe-pmc · retrieved 2026-09-26T01:27:04.635Z